Cerecor

$2.56
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.04 (+1.68%) Today
+$0.14 (+5.79%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Cerecor and other stocks, options, and ETFs commission-free!

About CERC

Cerecor, Inc. engages in the development and commercialization of treatments for rare pediatric and orphan diseases. Its lead product candidates include CERC-801, CERC-802, and CERC-803, which are therapies for inherited metabolic disorders known as Congenital Disorders of Glycosylation. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Rockville, MD. The listed name for CERC is Cerecor Inc. Common Stock.

CEO
Michael F. Cola
Employees
18
Headquarters
Rockville, Maryland
Founded
2011
Market Cap
181.28M
Price-Earnings Ratio
Dividend Yield
Average Volume
174.24K
High Today
$2.45
Low Today
$2.34
Open Price
$2.38
Volume
121.28K
52 Week High
$6.19
52 Week Low
$1.52

Collections

CERC Earnings

-$0.36
-$0.22
-$0.07
$0.07
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 10, After Hours

You May Also Like